Jayshree Chem. (506520)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales grew 24.29%, showing improving business activity.
• Piotroski F-score of 7/9 points to recent fundamental improvement.
• ROCE is marginally positive at 0.18%, suggesting some capital efficiency.
• Stock is trading at its 52-week high of ₹9.30, reflecting market interest.

Concerns

• Latest quarter net profit is ₹0 Cr and trailing ROE is negative at -0.38%.
• P/E is 0.00, meaning there is no demonstrable earnings stream.
• At ₹9.30 against book value of ₹3.70, stock trades at 2.51x book with subpar returns.
• No dividend, and debt/equity plus promoter holding are undisclosed.

AI Analysis

Jayshree Chem is a tiny commodity chemical player with an exciting-looking top line but no real earnings to show for it. The market cap is ₹27 crore, yet the latest quarter delivered ₹6 crore of sales and approximately zero net profit. Trailing ROE is -0.38% and ROCE is 0.18%; this is not a business earning a satisfactory return on capital. In fact, it is barely covering its cost of capital. Sales growth of 24.29% sounds nice, but profit growth of 250% is meaningless when starting from a base of nil profits. A P/E of 0.00 simply confirms there is no meaningful earnings number on which to hang a valuation. As a commodity chemical producer, Jayshree lacks pricing power and a durable moat. It is a price-taker in a cyclical industry. The balance sheet ratio is reported as N/A, so I cannot verify debt levels, and promoter holding is also undisclosed; that is a red flag for a small retail investor. Without these details, no intelligent owner would pay ₹9.30 per share for a book value of ₹3.70. At 2.51 times book, you are paying a premium for returns that are negative or near zero. There is no dividend to compensate while waiting. The Piotroski F-score of 7/9 hints at some recent fundamental improvement, and the stock sits at its 52-week high, so momentum may exist. But momentum is not value. In Benjamin Graham's language, there is no margin of safety here. This looks like a possible turnaround in early innings, but until profitability actually appears in quarterly numbers, I would rather watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer